PixoTest® POCT COVID-19 Antigen Test

iXensor

PixoTest® solution comprises a palm-sized analyser that reads test results accurately, a digital health pass App, an Admin App, and a HIPAA-grade health management web portal. The fully digitized testing and reporting design shortens the test-to-report time to 15 minutes. In addition to overcoming the lab testing limitations, the solution allows for scaling in large screening settings, thereby enabling business continuity and reopening.

::Features & Strengths

• Computer-powered accurate results in 15 minutes
• Concurrent reporting and digital health pass issuance
• Mobile health technology addresses fake test reports
• Superior accuracy meets EU standard

iXensor develops mobile health solutions, using hand-held devices boosting individual health and public health management.

iXensor turns ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017.

Our interdisciplinary team combines expertise in medical engineering, biochemistry, and information technology to develop innovative digital health solutions that empower tomorrow's connected healthcare.

Our product lines cover Women’s Health, Chronic, and Infectious Diseases and are powered by our core technology - PixoTech® platform protected by more than 50 international patents. PixoTech® serves as the platform-as-a-service model and will be the engine for our next phase of growth.

We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.

::Outreach & Partnerships

iXensor is looking to expand its footprint with worldwide partners.